{"transactions":[{"id":2642040,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":137579,"kind":"person","name":"KING RICHARD","position":1,"cik":"0001013702","reported_name":"KING RICHARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-06T16:12:02.000Z","date":"2021-06-30","kind":"other","acquired":true,"shares":2230,"price":9.5285,"value":21248.555,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired by Mr. King pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":2230,"source":{"system":"sec-edgar","filing":"0001209191-21-045418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013702/000120919121045418/doc4.xml","form_type":"4"}},{"id":2890976,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":137579,"kind":"person","name":"KING RICHARD","position":1,"cik":"0001013702","reported_name":"KING RICHARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-29T21:49:46.000Z","date":"2021-01-28","kind":"grant","acquired":true,"shares":155000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest over a four-year period commencing January 28, 2021, with 1/48th of the shares vesting on a monthly basis."}],"balance_after":155000,"derivative":{"exercise_price":20.08,"expiration_date":"2031-01-27","underlying":"Common Stock","underlying_shares":155000},"source":{"system":"sec-edgar","filing":"0001209191-21-006375","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013702/000120919121006375/doc4.xml","form_type":"4"}},{"id":3885414,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":137579,"kind":"person","name":"KING RICHARD","position":1,"cik":"0001013702","reported_name":"KING RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-06-22T16:47:52.000Z","date":"2018-06-21","kind":"sale","acquired":false,"shares":2501,"price":25.48,"value":63725.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the mandatory sale to cover withholding tax requirements of the issuer's equity incentive plan, the shares were sold to cover the tax obligation realized upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $25.42 to $25.53.  The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 696 shares purchased on 5/31/18 through the issuer's employee stock purchase plan."}],"balance_after":48856,"source":{"system":"sec-edgar","filing":"0001209191-18-039249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013702/000120919118039249/doc4.xml","form_type":"4"}},{"id":4004060,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":137579,"kind":"person","name":"KING RICHARD","position":1,"cik":"0001013702","reported_name":"KING RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-09T20:46:55.000Z","date":"2018-03-06","kind":"grant","acquired":true,"shares":66000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option shares shall vest as follows: 1/48th of the option shares shall vest on the 1st of each month beginning with April 1, 2018, subject to Reporting Person's Continuous Service as of each such date."}],"balance_after":66000,"derivative":{"exercise_price":25.66,"expiration_date":"2028-03-05","underlying":"Common Stock","underlying_shares":66000},"source":{"system":"sec-edgar","filing":"0001209191-18-018671","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013702/000120919118018671/doc4.xml","form_type":"4"}},{"id":4004059,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":137579,"kind":"person","name":"KING RICHARD","position":1,"cik":"0001013702","reported_name":"KING RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-09T20:46:55.000Z","date":"2018-03-06","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 25% of the total number of Restricted Stock Units will vest on each of March 20, 2019, March 20, 2020, March 20, 2021 and March 20, 2022, subject to Reporting Person's Continuous Service as of each such date."}],"balance_after":50661,"source":{"system":"sec-edgar","filing":"0001209191-18-018671","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013702/000120919118018671/doc4.xml","form_type":"4"}},{"id":4025006,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":137579,"kind":"person","name":"KING RICHARD","position":1,"cik":"0001013702","reported_name":"KING RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-01T12:14:41.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":10000,"price":25.07,"value":250700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased at prices ranging from $25.05 to $25.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,536 shares purchased on 11/30/17 through the issuer's employee stock purchase plan."}],"balance_after":39661,"source":{"system":"sec-edgar","filing":"0001209191-18-014826","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013702/000120919118014826/doc4.xml","form_type":"4"}},{"id":4332239,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":137579,"kind":"person","name":"KING RICHARD","position":1,"cik":"0001013702","reported_name":"KING RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-05T17:31:52.000Z","date":"2017-05-05","kind":"grant","acquired":true,"shares":168750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall become vested according to the following schedule: 25% of the shares subject to the option shall vest on April 28, 2018, and the remaining shares will vest in equal monthly installments over the next 36 months."}],"balance_after":168750,"derivative":{"exercise_price":17.4,"expiration_date":"2027-05-04","underlying":"Common Stock","underlying_shares":168750},"source":{"system":"sec-edgar","filing":"0001209191-17-030401","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013702/000120919117030401/doc4.xml","form_type":"4"}},{"id":4332238,"issuer":{"id":133085,"kind":"organization","name":"Adamas Pharmaceuticals Inc","symbol":"ADMS"},"owners":[{"id":137579,"kind":"person","name":"KING RICHARD","position":1,"cik":"0001013702","reported_name":"KING RICHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-05-05T17:31:52.000Z","date":"2017-05-05","kind":"grant","acquired":true,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest 1/4th on each of June 20, 2018, June 20, 2019, June 20, 2020, and June 20, 2021."}],"balance_after":28125,"source":{"system":"sec-edgar","filing":"0001209191-17-030401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013702/000120919117030401/doc4.xml","form_type":"4"}}]}